Coleman RE - Search Results

1

Clinical utility of biochemical markers of bone metabolism for improving the management of patients with advanced multiple myeloma.

Lipton A, Cook RJ, Coleman RE, Smith MR, Major P, Terpos E, Berenson JR. Lipton A, et al. Among authors: coleman re. Clin Lymphoma Myeloma. 2007 Mar;7(5):346-53. doi: 10.3816/CLM.2007.n.011. Clin Lymphoma Myeloma. 2007. PMID: 17562244 Review.

2

Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases.

Berenson JR, Rosen LS, Howell A, Porter L, Coleman RE, Morley W, Dreicer R, Kuross SA, Lipton A, Seaman JJ. Berenson JR, et al. Among authors: coleman re. Cancer. 2001 Apr 1;91(7):1191-200. doi: 10.1002/1097-0142(20010401)91:7<1191::aid-cncr1119>3.0.co;2-0. Cancer. 2001. PMID: 11283917 Clinical Trial.

3

Zoledronic acid in the treatment of hypercalcemia of malignancy: results of the international clinical development program.

Major PP, Coleman RE. Major PP, et al. Among authors: coleman re. Semin Oncol. 2001 Apr;28(2 Suppl 6):17-24. doi: 10.1016/s0093-7754(01)90261-1. Semin Oncol. 2001. PMID: 11346861 Review.

4

A phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases.

Body JJ, Greipp P, Coleman RE, Facon T, Geurs F, Fermand JP, Harousseau JL, Lipton A, Mariette X, Williams CD, Nakanishi A, Holloway D, Martin SW, Dunstan CR, Bekker PJ. Body JJ, et al. Among authors: coleman re. Cancer. 2003 Feb 1;97(3 Suppl):887-92. doi: 10.1002/cncr.11138. Cancer. 2003. PMID: 12548591 Free article. Clinical Trial.

5

Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion.

Rosen LS, Gordon DH, Dugan W Jr, Major P, Eisenberg PD, Provencher L, Kaminski M, Simeone J, Seaman J, Chen BL, Coleman RE. Rosen LS, et al. Among authors: coleman re. Cancer. 2004 Jan 1;100(1):36-43. doi: 10.1002/cncr.11892. Cancer. 2004. PMID: 14692022 Free article. Clinical Trial.

6

Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors.

Brown JE, Cook RJ, Major P, Lipton A, Saad F, Smith M, Lee KA, Zheng M, Hei YJ, Coleman RE. Brown JE, et al. Among authors: coleman re. J Natl Cancer Inst. 2005 Jan 5;97(1):59-69. doi: 10.1093/jnci/dji002. J Natl Cancer Inst. 2005. PMID: 15632381

7

Predictive value of bone resorption and formation markers in cancer patients with bone metastases receiving the bisphosphonate zoledronic acid.

Coleman RE, Major P, Lipton A, Brown JE, Lee KA, Smith M, Saad F, Zheng M, Hei YJ, Seaman J, Cook R. Coleman RE, et al. J Clin Oncol. 2005 Aug 1;23(22):4925-35. doi: 10.1200/JCO.2005.06.091. Epub 2005 Jun 27. J Clin Oncol. 2005. PMID: 15983391

8

A study of the biological receptor activator of nuclear factor-kappaB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer.

Body JJ, Facon T, Coleman RE, Lipton A, Geurs F, Fan M, Holloway D, Peterson MC, Bekker PJ. Body JJ, et al. Among authors: coleman re. Clin Cancer Res. 2006 Feb 15;12(4):1221-8. doi: 10.1158/1078-0432.CCR-05-1933. Clin Cancer Res. 2006. PMID: 16489077 Clinical Trial.

9

Advances in treating metastatic bone cancer: summary statement for the First Cambridge Conference.

Lipton A, Berenson JR, Body JJ, Boyce BF, Bruland OS, Carducci MA, Cleeland CS, Clohisy DR, Coleman RE, Cook RJ, Guise TA, Pearse RN, Powles TJ, Rogers MJ, Roodman GD, Smith MR, Suva LJ, Vessella RL, Weilbaecher KN, King L. Lipton A, et al. Among authors: coleman re. Clin Cancer Res. 2006 Oct 15;12(20 Pt 2):6209s-6212s. doi: 10.1158/1078-0432.CCR-06-1213. Clin Cancer Res. 2006. PMID: 17062702 Free PMC article.

10

Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel.

Aapro M, Abrahamsson PA, Body JJ, Coleman RE, Colomer R, Costa L, Crinò L, Dirix L, Gnant M, Gralow J, Hadji P, Hortobagyi GN, Jonat W, Lipton A, Monnier A, Paterson AH, Rizzoli R, Saad F, Thürlimann B. Aapro M, et al. Among authors: coleman re. Ann Oncol. 2008 Mar;19(3):420-32. doi: 10.1093/annonc/mdm442. Epub 2007 Sep 28. Ann Oncol. 2008. PMID: 17906299 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,028 results

Search Page